A Case of Invasive Pulmonary Aspergillosis Cured with Liposomal Amphotericin, Granulocyte Transfusion and Surgery in an Allogeneic Hemopoietic Stem Cell Transplantation Recipient / 대한혈액학회지
Korean Journal of Hematology
;
: 625-629, 1999.
Artículo
en Coreano
| WPRIM
| ID: wpr-720669
ABSTRACT
The prognosis of invasive aspergillosis in allogeneic bone marrow transplantation recipients is grave in the absence of bone marrow recovery in spite of antifungal treatment with amphotericin B. Beneficial role of granulocyte transfusion in neutropenic patients with fungal infection has been re-evaluated since granulocyte colony-stimulating factor made effective collection of granulocyte possible. And Liposomal amphotericin appears to be an effective alternative to conventional amphotericin B with much less toxicity. A 34-year-old patient with acute lymphoblastic leukemia developed invasive pulmonary aspergillosis during very early period of allogeneic hemopoietic stem cell transplantation. We treated the case successfully with liposomal amphotericin and granulocyte transfusion and surgery in spite of known high mortality of invasive aspergillosis in transplantation patients.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Pronóstico
/
Aspergilosis
/
Células Madre
/
Médula Ósea
/
Leucemia
/
Anfotericina B
/
Mortalidad
/
Factor Estimulante de Colonias de Granulocitos
/
Trasplante de Médula Ósea
/
Trasplante de Células Madre
Tipo de estudio:
Estudio pronóstico
Límite:
Adulto
/
Humanos
Idioma:
Coreano
Revista:
Korean Journal of Hematology
Año:
1999
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS